Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Molecular Models02:00

Molecular Models

42.7K
Physical models representing molecular architectures of chemical compounds play essential roles in understanding chemistry. The use of molecular models makes it easier to visualize the structures and shapes of atoms and molecules.
42.7K
Cycloaddition Reactions: MO Requirements for Thermal Activation01:16

Cycloaddition Reactions: MO Requirements for Thermal Activation

3.9K
Thermal cycloadditions are reactions where the source of activation energy needed to initiate the reaction is provided in the form of heat. A typical example of a thermally-allowed cycloaddition is the Diels–Alder reaction, which is a [4 + 2] cycloaddition. In contrast, a [2 + 2] cycloaddition is thermally forbidden.
3.9K
Predicting Molecular Geometry02:27

Predicting Molecular Geometry

42.3K
VSEPR Theory for Determination of Electron Pair Geometries
42.3K
Mechanistic Models: Compartment Models in Algorithms for Numerical Problem Solving01:29

Mechanistic Models: Compartment Models in Algorithms for Numerical Problem Solving

179
Mechanistic models play a crucial role in algorithms for numerical problem-solving, particularly in nonlinear mixed effects modeling (NMEM). These models aim to minimize specific objective functions by evaluating various parameter estimates, leading to the development of systematic algorithms. In some cases, linearization techniques approximate the model using linear equations.
In individual population analyses, different algorithms are employed, such as Cauchy's method, which uses a...
179
Cycloaddition Reactions: MO Requirements for Photochemical Activation01:12

Cycloaddition Reactions: MO Requirements for Photochemical Activation

2.4K
Some cycloaddition reactions are activated by heat, while others are initiated by light. For example, a [2 + 2] cycloaddition between two ethylene molecules occurs only in the presence of light. It is photochemically allowed but thermally forbidden.
2.4K
Ziegler–Natta Chain-Growth Polymerization: Overview01:17

Ziegler–Natta Chain-Growth Polymerization: Overview

3.7K
Ziegler–Natta polymerization is another form of addition or chain‐growth polymerization used for synthesizing linear polymers over branched polymers. The catalyst used for polymerization is the Ziegler–Natta catalyst, named after Karl Ziegler and Giulio Natta, who developed it in 1953. This catalyst is an organometallic complex of titanium tetrachloride and triethyl aluminum, with the active form of the catalyst being an alkyl titanium compound. Using the Ziegler–Natta...
3.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Qsarna: An Online Tool for Smart Chemical Space Navigation in Drug Design.

Journal of chemical information and modeling·2025
Same author

PROFIS: Design of Target-Focused Libraries by Probing Continuous Fingerprint Space with Recurrent Neural Networks.

Journal of chemical information and modeling·2025
Same author

Generative Models Should at Least Be Able to Design Molecules That Dock Well: A New Benchmark.

Journal of chemical information and modeling·2023
Same author

How can SHAP values help to shape metabolic stability of chemical compounds?

Journal of cheminformatics·2021
Same author

2D SIFt: a matrix of ligand-receptor interactions.

Journal of cheminformatics·2021
Same journal

OpenStats: how to combine statistics and research data management (RDM) to leverage efficient scientific data analysis by guided statistics.

Journal of cheminformatics·2026
Same journal

Unified heterogeneity-aware benchmark of drug synergy prediction: a cross-study analysis of traditional machine learning and graph deep learning models.

Journal of cheminformatics·2026
Same journal

Count your bits: fingerprint benchmarking to assess broad chemical space representation.

Journal of cheminformatics·2026
Same journal

Sampling out-of-distribution chemical spaces via Bayesian flow.

Journal of cheminformatics·2026
Same journal

Hold on tight: the kinetic profiling of opioid receptor ligands using the CORAL-MD.

Journal of cheminformatics·2026
Same journal

Transformer-accelerated discovery of inhibitors targeting the RpsA<sub>Δ438</sub> deletion in PZA-resistant tuberculosis.

Journal of cheminformatics·2026
See all related articles

Related Experiment Video

Updated: Nov 21, 2025

Curation of Computational Chemical Libraries Demonstrated with Alpha-Amino Acids
08:21

Curation of Computational Chemical Libraries Demonstrated with Alpha-Amino Acids

Published on: April 13, 2022

2.9K

Mol-CycleGAN: a generative model for molecular optimization.

Łukasz Maziarka1,2, Agnieszka Pocha3, Jan Kaczmarczyk4

  • 1Ardigen, Podole 76, 30-394, Cracow, Poland. lukasz.maziarka@ardigen.com.

Journal of Cheminformatics
|January 12, 2021
PubMed
Summary
This summary is machine-generated.

Mol-CycleGAN generates optimized drug molecules similar to original structures. This AI model improves drug design by optimizing properties like penalized logP, outperforming previous methods.

Keywords:
Deep learningDrug designGenerative modelsMolecular optimization

More Related Videos

Interactive Molecular Model Assembly with 3D Printing
06:15

Interactive Molecular Model Assembly with 3D Printing

Published on: August 13, 2020

10.6K
Modeling an Enzyme Active Site using Molecular Visualization Freeware
14:37

Modeling an Enzyme Active Site using Molecular Visualization Freeware

Published on: December 25, 2021

10.8K

Related Experiment Videos

Last Updated: Nov 21, 2025

Curation of Computational Chemical Libraries Demonstrated with Alpha-Amino Acids
08:21

Curation of Computational Chemical Libraries Demonstrated with Alpha-Amino Acids

Published on: April 13, 2022

2.9K
Interactive Molecular Model Assembly with 3D Printing
06:15

Interactive Molecular Model Assembly with 3D Printing

Published on: August 13, 2020

10.6K
Modeling an Enzyme Active Site using Molecular Visualization Freeware
14:37

Modeling an Enzyme Active Site using Molecular Visualization Freeware

Published on: December 25, 2021

10.8K

Area of Science:

  • Medicinal Chemistry
  • Artificial Intelligence in Drug Discovery
  • Computational Chemistry

Background:

  • Drug development faces challenges in optimizing chemical compound structures for desired properties.
  • Current methods for molecular optimization are complex and time-consuming.

Purpose of the Study:

  • To introduce Mol-CycleGAN, a novel CycleGAN-based model for generating optimized molecules.
  • To improve the efficiency and effectiveness of the molecular design process in drug discovery.

Main Methods:

  • Developed Mol-CycleGAN, a generative adversarial network model based on CycleGAN architecture.
  • Evaluated model performance on optimizing structural properties (halogen groups, aromatic rings) and physicochemical properties (penalized logP).
  • Compared performance against existing methods for molecular optimization tasks.

Main Results:

  • Mol-CycleGAN successfully generates structurally similar molecules with optimized target properties.
  • The model demonstrates significant outperformance in optimizing penalized logP for drug-like molecules compared to prior approaches.
  • Effective optimization of structural features like halogen groups and aromatic ring counts was achieved.

Conclusions:

  • Mol-CycleGAN offers a promising approach for accelerating and enhancing molecular design in drug discovery.
  • The model's ability to maintain structural similarity while optimizing properties is a key advantage.
  • This AI-driven method shows potential for streamlining the development of novel therapeutics.